Pathophysiology of the antiphospholipid syndrome
- 8 August 2005
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (8) , 1854-1860
- https://doi.org/10.1111/j.1538-7836.2005.01359.x
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Binding of β2–glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cellsBlood, 2005
- Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazepBlood, 2004
- A two‐step coagulation test to identify antiβ2‐glycoprotein I lupus anticoagulantsJournal of Thrombosis and Haemostasis, 2004
- Antiphospholipid syndromeThe Hematology Journal, 2004
- Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolismThrombosis and Haemostasis, 2004
- Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeBlood, 2003
- Anti-β2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent bindingLupus, 2003
- Solution Structure of Human and Bovine β2-Glycoprotein I Revealed by Small-angle X-ray ScatteringJournal of Molecular Biology, 2002
- Dimers of β2-Glycoprotein I Mimic thein Vitro Effects of β2-Glycoprotein I-Anti-β2-glycoprotein I Antibody ComplexesJournal of Biological Chemistry, 2001
- beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.Journal of Clinical Investigation, 1998